We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
http://www.lse.co.uk/ShareTrades.asp?shareprice=TYR&share=tyratech_(regs)
Well I just checked and I can only buy tyru. It looks like tyr are restricted shares. Think this explains it: Taken from the RNS on TYR: The Company currently has 168,776,305 common shares of US$0.001 each in issue. The number of restricted common shares currently trading under TIDM 'TYR' is 117,352,576 and the number of unrestricted common shares currently trading under TIDM 'TYRU' is 51,423,729.
I expect the demand has been bigger over there with the recent news as business is based in Morrisville, US, so they have marked it up.
Thanks Doze, wonder why the US one has had a higher rise? (May be exchange rate considerations possibly)
tryu is a listing for the US but the shares are registered on AIM under TYR https://www.google.co.uk/finance?q=LON%3ATYRU&ei=fMH4UqAfiILAA-Uf
What's the difference? I see Tyru has had a bigger rise but can someone please briefly explain the difference? (the mail article links to tyr). Also this would be the first time you would get excited about a breakout of head lice!
This won't but TRYU might do as that is the real ticker!!!!
will close at 8p tomorrow
Hi there , yes i was very pleased to see the article also , going to be interesting to see what happens next week to thr SP. BTW , did you ever get hold of that company note from First Columbus - getting a bit old now as the date on it was may 2013 - still however IMO the best summary of the prospects here. If you are interested in getting a copy from me - my email is thebigc007@mail.com regards BigC
Just what this share needed, a buy rec n the Daily Mail. Yes, bodes well for this coming week. Amazon? First I've heard of these discussions although they must announce something soon on UK distribution deal(s).
Great feature on TYR today, should bode well for the SP IMO DYOR etc
Very interested actually and a good development, a build up of sales should follow, only a tiny holding though. Would be nice if other chains stocked up.
No interest whatsoever here? This Walmart deal should attract the rest of the major retailers in the USA. No mention of exclusivity. Next up I'd guess a similar deal with major supermarket chains/pharmacies. Novartis news can't be far off either.
No luck with that, no response from First Columbus. Oh well, never mind. I took advantage of the recent drop to add a few hundred K at 4.5p. Great price on a long term view.
trade?.............
November 06 2013, 12:04pm The company's products are based on natural essential oils and are designed to act against pests but have no effect on humansThe company's products are based on natural essential oils and are designed to act against pests but have no effect on humans Natural insecticide specialist TyraTech (LON:TYR) has product launches imminent in Europe and the US, says broker N+1 Singer, which has started covering the stock. In a pivotal year ahead, its deal with Novartis Animal Health and the Envance Technologies joint venture, established with leading US pest control company AMVAC, could transform the company over the next 12 to 24 months, reckons analyst Dr Jens Lindqvist. "TyraTech has achieved product registrations and approvals in both Europe and the US, allowing near-term launches through each of its portals," said Lindqvist. The analyst also notes that a preliminary agreement with a leading pharmacy chain in the US has already been negotiated for Vamousse - the firm’s head lice treatment - for commercial launch in 2014 and more deals are expected in both Europe and the US. The US chain in question has around 8,500 stores in its portfolio, representing close to 15% of retail pharmacy stores in the USA. TyraTech's business areas are personal care, which includes the head lice treatments; animal health, which is treatments for use in animals; and Envance Technologies to commercialise pesticides for household, agricultural and garden use. The company's products are based on natural essential oils and are designed to act against pests but have no effect on humans. The broker's 10 year valuation based on discounted cash flow puts the value at the firm at 9.3 pence, representing a 65% increase on current levels. This is assuming the successful launch of the firm's personal care products in the USA and Europe.
Logged in to the First Columbus site and completed the registration but they need a while to process it. Thanks for that, very very useful.
Thanks very much BigCO. I will take a look at the FC website in a minute. It's always nice to have feedback from these presentations as I can't get to them myself as I'm not in the U.K. There was, apparently another broker note from FC out today reiterating their 12p price target. How they arrive at any target at the moment is beyond me as they have no idea what the Novartis agreement will deliver and VaMousse has yet to hit the shelves anywhere. I presume you saw the 2 trades in TYRU shares today, 2 x 900k @ 5.5p. I added a few myself on the back of that - Director buying methinks; should know tomorrow. FWIW, I have built a decent holding here, getting on for the 1m now. The only negative I can see is the possibility of another fund raise next spring. The positives you are well aware of. Thanks & good luck!!
Hi again - when I was at the presentation , there where documents available on this company prepared by stockbrokers First Columbus, which give an exhaustive review of this company - arguably better and more inforative than the Presentation Documents themselves. To get an extremely accurate view of what this company is all about - all you need to do is have sight of this , and IMPO it is one of the very best documents of its type that I have seen. I rang up First Columbus earlier to ask how anyone else could get a viewing of same. All you have to do - if interested ( anduyou should be IMPO !! ) - go to the website www.first-columbus.com and log in - I believe that you will be asked if you are a sophisticated private investor - And if you get that right - then go to the bit marked Research , and you should then have a lead into this company All the best and please post what you think . BigC.
Re Walmarts - got the info direct after the presentation - have a lot more good info - -now that some one has replied , I will post more tomorrow . BigC
Thanks for posting that BigCO. I wasn't aware of the Walmart agreement - a couple of posters on another site were there as well and there was no mention of it. I also wasn't aware they had spent 50 million($ or £ is irrelevant!!) on development. Nice to see AR buying just after the close period. He has continuously been a buyer of stock since his first purchase in April 2009. It's quite reassuring. I'm still getting up to speed with this company but I really do like what I have uncovered so far. Everyone who has seen their products is suitably impressed so why not the general public?!! Not sure what new to expect next but Bruno Jactel did say they were in a period of agreeing distribution deals for the big roll-out next year. Possibly news from Novartis in the mean time? I noticed the chemical sector has an average PE ratio of 15. TyraTech would only have to make £650k of profits to attain that rating so any positive news on sales would do the share price no harm.
Really cant believe that you have " thumb trouble " LOL.